XYLT1 Gene: Xylosyltransferase 1
Key enzyme in proteoglycan biosynthesis and its role in skeletal disorders and cancer
Gene Information Card
| Symbol | XYLT1 |
|---|---|
| Full Name | Xylosyltransferase 1 |
| Gene Type | Protein-coding |
| Chromosomal Location | 16p12.3 |
| NCBI Gene ID | 64131 ncbi.nlm.nih.gov/gene/64131 |
| Ensembl ID | ENSG00000103495 |
| UniProt ID | Q86Y38 |
| OMIM ID | 608124 |
| HGNC ID | 15516 |
| Aliases | XT1, XT-I, XylT1 |
Description
The XYLT1 gene encodes xylosyltransferase 1, an enzyme that catalyzes the transfer of xylose from UDP-xylose to specific serine residues of proteoglycan core proteins, initiating the biosynthesis of glycosaminoglycan chains. This modification is essential for the function of proteoglycans in extracellular matrix organization, cell signaling, and development. Mutations in XYLT1 are associated with skeletal dysplasias and have been implicated in cancer progression.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Desbuquois dysplasia type 2 | Loss-of-function mutations impair proteoglycan synthesis, leading to skeletal abnormalities | OMIM #615777; Bui et al., 2014, Am J Hum Genet |
| Multiple osteochondromas | Altered heparan sulfate proteoglycan biosynthesis due to XYLT1 mutations | OMIM #133700; Isidor et al., 2014, Hum Mutat |
| Breast cancer | Overexpression of XYLT1 promotes tumor growth and metastasis via altered proteoglycan signaling | COSMIC; PubMed 25695632 |
| Pancreatic cancer | Upregulation of XYLT1 correlates with poor prognosis and increased cell migration | COSMIC; PubMed 28991257 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 12.5 | Medium |
| Kidney | 10.2 | Medium |
| Lung | 8.9 | Medium |
| Brain | 6.1 | Low |
| Heart | 4.3 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | 15.3 | Hepatocellular carcinoma cell line |
| A549 | 11.7 | Lung adenocarcinoma cell line |
| MCF7 | 9.8 | Breast cancer cell line |
| HEK293 | 7.2 | Embryonic kidney cells |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1234C>T (p.Arg412*) | Nonsense | Rare | Loss of function; associated with Desbuquois dysplasia |
| c.567G>A (p.Trp189*) | Nonsense | Rare | Loss of function; skeletal dysplasia |
| c.890A>G (p.Tyr297Cys) | Missense | Rare | Reduced enzymatic activity; multiple osteochondromas |
| c.1456G>A (p.Gly486Ser) | Missense | Rare | Impaired xylosyltransferase activity |
Mutation functional classification
Loss of Function (LOF)
Nonsense and missense mutations that reduce or abolish xylosyltransferase activity, leading to defective proteoglycan synthesis and skeletal dysplasias.
Gain of Function (GOF)
Not well documented; overexpression in cancers may act as a gain-of-function by increasing proteoglycan modification.
Dominant Negative (DN)
No evidence for dominant-negative effects; XYLT1 mutations are typically recessive.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Proteoglycan biosynthesis (Reactome R-HSA-1793185)
• Chondroitin sulfate/dermatan sulfate biosynthesis (KEGG hsa00532)
• Heparan sulfate/heparin biosynthesis (KEGG hsa00534)
Protein Summary
Xylosyltransferase 1 (UniProt Q86Y38) is a 959-amino acid type II transmembrane protein localized to the Golgi apparatus. It catalyzes the initial and rate-limiting step in glycosaminoglycan chain synthesis by transferring xylose from UDP-xylose to serine residues of proteoglycan core proteins. The protein contains a catalytic domain with a DXD motif essential for enzyme activity. Mutations in XYLT1 disrupt proteoglycan function, leading to skeletal disorders and altered cancer cell behavior.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| GXYLT1 Knockout HEK293 Cell Line | EDJ-KQ1032 | Human | 283464 | Details Get a Quote |
| RXYLT1 Knockout HEK293 Cell Line | EDJ-KQ7008 | Human | 10329 | Details Get a Quote |
| XXYLT1 Knockout HEK293 Cell Line | EDJ-KQ11361 | Human | 152002 | Details Get a Quote |
| XYLT1 Knockout HEK293 Cell Line | EDJ-KQ16165 | Human | 64131 | Details Get a Quote |
| GXYLT1 Knockout A-549 Cell Line | EDJ-KQ20135 | Human | 283464 | Details Get a Quote |
| GXYLT1 Knockout HCT 116 Cell Line | EDJ-KQ20136 | Human | 283464 | Details Get a Quote |
| GXYLT1 Knockout HeLa Cell Line | EDJ-KQ20137 | Human | 283464 | Details Get a Quote |
| RXYLT1 Knockout A-549 Cell Line | EDJ-KQ31744 | Human | 10329 | Details Get a Quote |
| RXYLT1 Knockout HCT 116 Cell Line | EDJ-KQ31745 | Human | 10329 | Details Get a Quote |
| RXYLT1 Knockout HeLa Cell Line | EDJ-KQ31746 | Human | 10329 | Details Get a Quote |
| XXYLT1 Knockout A-549 Cell Line | EDJ-KQ39541 | Human | 152002 | Details Get a Quote |
| XXYLT1 Knockout HCT 116 Cell Line | EDJ-KQ39542 | Human | 152002 | Details Get a Quote |
| XXYLT1 Knockout HeLa Cell Line | EDJ-KQ39543 | Human | 152002 | Details Get a Quote |
| XYLT1 Knockout A-549 Cell Line | EDJ-KQ47363 | Human | 64131 | Details Get a Quote |
| XYLT1 Knockout HCT 116 Cell Line | EDJ-KQ47364 | Human | 64131 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records